Update on trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties

Cancer Invest. 1991;9(2):159-72. doi: 10.3109/07357909109044227.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adult
  • Aged
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Antiprotozoal Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Resistance
  • Female
  • Folic Acid Antagonists / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Experimental / drug therapy
  • Quinazolines / pharmacology
  • Quinazolines / therapeutic use*
  • Quinazolines / toxicity
  • Trimetrexate

Substances

  • Antineoplastic Agents
  • Antiprotozoal Agents
  • Folic Acid Antagonists
  • Quinazolines
  • Trimetrexate